Macerich Stock Forecast, Price & News

Macerich (NYSE:MAC) Frequently Asked Questions

Is Macerich a buy right now?

12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Macerich in the last twelve months. There are currently 5 sell ratings, 5 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Macerich stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MAC, but not buy additional shares or sell existing shares.
View analyst ratings for Macerich or view top-rated stocks.

How has Macerich's stock price been impacted by COVID-19?

Macerich's stock was trading at $15.37 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, MAC shares have increased by 17.8% and is now trading at $18.10.
View which stocks have been most impacted by COVID-19.

When is Macerich's next earnings date?

Macerich is scheduled to release its next quarterly earnings announcement on Thursday, February 10th 2022.
View our earnings forecast for Macerich.

How were Macerich's earnings last quarter?

The Macerich Company (NYSE:MAC) released its quarterly earnings data on Wednesday, November, 3rd. The real estate investment trust reported $0.50 EPS for the quarter, topping analysts' consensus estimates of $0.43 by $0.07. The real estate investment trust earned $212.14 million during the quarter, compared to analyst estimates of $200.58 million. Macerich had a negative trailing twelve-month return on equity of 5.39% and a negative net margin of 19.58%. Macerich's revenue for the quarter was up 14.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.52 earnings per share.
View Macerich's earnings history.

How often does Macerich pay dividends? What is the dividend yield for Macerich?

Macerich announced a quarterly dividend on Thursday, October 28th. Investors of record on Tuesday, November 9th will be given a dividend of $0.15 per share on Friday, December 3rd. This represents a $0.60 dividend on an annualized basis and a yield of 3.31%. The ex-dividend date of this dividend is Monday, November 8th.
View Macerich's dividend history.

Is Macerich a good dividend stock?

Macerich pays an annual dividend of $0.60 per share and currently has a dividend yield of 3.24%.
View Macerich's dividend history.

What guidance has Macerich issued on next quarter's earnings?

Macerich updated its FY 2021 earnings guidance on Wednesday, November, 10th. The company provided EPS guidance of $1.920-$2.000 for the period. The company issued revenue guidance of -.

What price target have analysts set for MAC?

12 brokers have issued 12 month price targets for Macerich's shares. Their forecasts range from $12.00 to $35.00. On average, they expect Macerich's share price to reach $18.42 in the next twelve months. This suggests a possible upside of 1.7% from the stock's current price.
View analysts' price targets for Macerich or view top-rated stocks among Wall Street analysts.

Who are Macerich's key executives?

Macerich's management team includes the following people:

• Thomas E. O'Hern, Chief Executive Officer & Director
• Edward C. Coppola, President & Director
• Olivia Bartel Leigh, Executive VP-Portfolio Operations & People
• Scott W. Kingsmore, CFO, Treasurer & Senior Executive Vice President
• Michael Slavin, Senior Vice President-Information Technology

What is Art Coppola's approval rating as Macerich's CEO?

60 employees have rated Macerich CEO Art Coppola on Glassdoor.com. Art Coppola has an approval rating of 68% among Macerich's employees.

Who are some of Macerich's key competitors?

Some companies that are related to Macerich include Simon Property Group (SPG), Realty Income (O), Kimco Realty (KIM), Federal Realty Investment Trust (FRT), National Retail Properties (NNN), Agree Realty (ADC), Kite Realty Group Trust (KRG), Retail Opportunity Investments (ROIC), Tanger Factory Outlet Centers (SKT), Acadia Realty Trust (AKR), Getty Realty (GTY), Alexander's (ALX), Saul Centers (BFS), RPT Realty (RPT) and Urstadt Biddle Properties (UBA).
View all of MAC's competitors.

What other stocks do shareholders of Macerich own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Macerich investors own include Energy Transfer (ET), Simon Property Group (SPG), AT&T (T), Wells Fargo & Company (WFC), Annaly Capital Management (NLY), Enterprise Products Partners (EPD), Intel (INTC), New Residential Investment (NRZ), AbbVie (ABBV) and Pfizer (PFE).

What is Macerich's stock symbol?

Macerich trades on the New York Stock Exchange (NYSE) under the ticker symbol "MAC."

Who are Macerich's major shareholders?

Macerich's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (14.20%), Smead Capital Management Inc. (3.94%), Aew Capital Management L P (2.34%), Geode Capital Management LLC (1.84%), Two Sigma Advisers LP (1.48%) and Dimensional Fund Advisors LP (1.34%). Company insiders that own Macerich stock include Ann C Menard, Christopher J Zecchini, Dana K Anderson, Doug J Healey, Edward C Coppola, Hern Thomas E O, John H Alschuler Jr, Kenneth Volk, Steven L Soboroff and Teachers Pension Plan Ontario.
View institutional ownership trends for Macerich.

Which institutional investors are selling Macerich stock?

MAC stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Voloridge Investment Management LLC, Virginia Retirement Systems ET AL, Citadel Advisors LLC, Jane Street Group LLC, Aew Capital Management L P, Two Sigma Advisers LP, and Migdal Insurance & Financial Holdings Ltd.. Company insiders that have sold Macerich company stock in the last year include Christopher J Zecchini, Dana K Anderson, Steven L Soboroff, and Teachers Pension Plan Ontario.
View insider buying and selling activity for Macerich or view top insider-selling stocks.

Which institutional investors are buying Macerich stock?

MAC stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Letko Brosseau & Associates Inc., Geode Capital Management LLC, Candriam Luxembourg S.C.A., Bank of New York Mellon Corp, Dimensional Fund Advisors LP, Smead Capital Management Inc., and HighTower Advisors LLC. Company insiders that have bought Macerich stock in the last two years include Ann C Menard, Dana K Anderson, Doug J Healey, Edward C Coppola, Hern Thomas E O, John H Alschuler Jr, Kenneth Volk, and Steven L Soboroff.
View insider buying and selling activity for Macerich or or view top insider-buying stocks.

How do I buy shares of Macerich?

Shares of MAC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Macerich's stock price today?

One share of MAC stock can currently be purchased for approximately $18.10.

How much money does Macerich make?

Macerich has a market capitalization of $3.86 billion and generates $786.03 million in revenue each year. The real estate investment trust earns $-230.20 million in net income (profit) each year or ($1.14) on an earnings per share basis.

How many employees does Macerich have?

Macerich employs 665 workers across the globe.

Does Macerich have any subsidiaries?

The following companies are subsidiares of Macerich: Amphenol Sincere Industrial Product Gyarto. Kft.

When was Macerich founded?

Macerich was founded in 1964.

What is Macerich's official website?

The official website for Macerich is www.macerich.com.

Where are Macerich's headquarters?

Macerich is headquartered at 401 WILSHIRE BLVD STE 700, SANTA MONICA CA, 90401.

How can I contact Macerich?

Macerich's mailing address is 401 WILSHIRE BLVD STE 700, SANTA MONICA CA, 90401. The real estate investment trust can be reached via phone at (310) 394-6000, via email at [email protected], or via fax at 310-395-2791.